Reactive (AA) systemic amyloidosis

British Medical Journal

Volumn 312, Issue 7038, 1996, Pages 1087-1089

  Allen, A R ^a   Scott, J ^b   Clutterbuck, E ^b   Walport, M J ^b   Davies, K ^b   Wilding, J ^b   Thompson, M ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE PHASE RESPONSE; ADULT; AMYLOIDOSIS; CASE REPORT; FEMALE; HUMAN; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; SHORT SURVEY;

EID: 0029926070     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (8)

1. Lowenstein J, Gallo G. Remission of the nephrotic syndrome in renal amyloidosis. N Engl J Med 1970;282:128-32.
2. Tang AL, Davies DR, Wing AJ. Remission of nephrotic syndrome in amyloidosis associated with a hypernephroma. Clin Nephrol 1989;32:225-8.
3. Falck HM, Tornroth T, Skrifvars B, Wegelius O. Resolution of renal amyloidosis secondary to rheumatoid arthritis. Acta Medica Scandinavica 1979;205:651-6.
4. Perfetti V, Bellotti V, Maggi A, Arbustini E, De Benedetti F, Paulli M, et al. Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localised Castleman's disease. Am J Haematol 1994;46:189-93.
5. Dikman SH, Kahn T, Gribetz D, Churg J. Resolution of renal amyloidosis. Am J Med 1977;63:430-3.
6. Michael J, Jones NF. Spontaneous remission of nephrotic syndrome in renal amyloidosis. BMJ 1978;i:1592-3.
7. Heeg JE, de Jong PE, Vriesendorp R, de Zeeuw D. Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril. Am J Nephrol 1990;10:94-7.
8. Fuiano G, Conte G, Sepe V, Balletta M, Cianfrone P, Libeta C, et al. Acute effects of cyclosporin on renal haemodynamics and the urinary protein excretion in patients with the nephrotic syndrome. Nephron 1991;59:369-74.